Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate by Tim R. Cressey, Oraphan Siriprakaisil, Rachel W. Kubiak, Virat Klinbuayaem, Pra-ornsuda Sukrakanchana, Justice Quame-Amaglo, Hideaki Okochi, Yardpiroon Tawon, Ratchada Cressey, Jared M. Baeten, Monica Gandhi, Paul K. Drain

Subjects: Get full text

Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer by Pin-Nan Cheng, Ming-Lung Yu

Get full text

A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B by Ankur Jindal, Ashish Vyas, Manoj Sharma, Guresh Kumar, Shiv K Sarin

“…Background/Aim: Acute-on-chronic liver failure (ACLF-B) in spontaneous reactivation of chronic hepatitis B (SR-CHB) has high mortality. Tenofovir disoproxil fumarate (TDF) improves survival by ~40% in ACLF-B but is potentially nephrotoxic. …”
Get full text

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV by Inès Devred, Kick Kayembe, Nadia Valin, Hayette Rougier, Bruce Wuembulua Shinga, Sidonie Lambert-Niclot, Thibault Chiarabini, Marie-Caroline Meyohas, Karine Lacombe

“…Doravirine has been available since 2019 in combination with tenofovir disoproxil fumarate and lamivudine and has not been evaluated as a PEP. …”
Get full text

Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya. by Mercy Jelagat Karoney, Mathew Kirtptonui Koech, Evangeline Wawira Njiru, Willis Dixon Owino Ong'or

“…<h4>Introduction</h4>Tenofovir Disoproxil Fumarate (TDF) is the most widely used Anti-Retroviral Therapy (ART) drug due to its potency, safety profile and World Health Organization (WHO) recommendation. …”
Get full text

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile by Squillace N, Ricci E, Menzaghi B, De Socio GV, Passerini S, Martinelli C, Mameli MS, Maggi P, Falasca K, Cordier L, Celesia BM, Salomoni E, Di Biagio A, Pellicanò GF, Bonfanti P

“…Barresi&rdquo;, Unit of Infectious Diseases, University of Messina, Messina, ItalyCorrespondence: Nicola SquillaceInfectious Diseases Unit, Azienda Socio Sanitaria Territoriale di MONZA, San Gerardo Hospital-University of Milano-Bicocca, Via Pergolesi 33, Monza 20900, ItalyTel +390392339588Fax +390392339327Email nicolasquillace74@gmail.comObjective: We aimed to investigate the effect of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) on the hepatic safety and metabolic profile.Methods: Consecutive HIV patients, enrolled in the Surveillance Cohort Long-term Toxicity Antiretrovirals/Antivirals (SCOLTA) project, switching from TDF to TAF were included. …”
Get full text

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV. by Calvin Q Pan, Ting-Tsung Chang, Si Hyun Bae, Maurizia Brunetto, Wai-Kay Seto, Carla S Coffin, Susanna K Tan, Shuyuan Mo, John F Flaherty, Anuj Gaggar, Mindie H Nguyen, Mustafa Kemal Çelen, Alexander Thompson, Edward J Gane

“…<h4>Background/purpose</h4>Use of tenofovir disoproxil fumarate (TDF) improves patient outcomes in preventing mother-to-child transmission (pMTCT) of the hepatitis B virus (HBV) in mothers with chronic HBV and high viral loads. …”
Get full text

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring by Andrea R. Thurman, Jacques Ravel, Pawel Gajer, Mark A. Marzinke, Louise A. Ouattara, Terry Jacot, M. Melissa Peet, Meredith R. Clark, Gustavo F. Doncel

Subjects: Get full text

Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya by Mercy Jelagat Karoney, Mathew Kirtptonui Koech, Evangeline Wawira Njiru, Willis Dixon Owino Ong’or

“…<h4>Introduction</h4> Tenofovir Disoproxil Fumarate (TDF) is the most widely used Anti-Retroviral Therapy (ART) drug due to its potency, safety profile and World Health Organization (WHO) recommendation. …”
Get full text

Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method by Na Yang, Guanlun Zhou, Xiaoliang Cheng, Jun He, Yan Chen, Chao Chen, Meijuan Li, Jiajia Ge, Min Wang, Tianqi Zhang, Weihong Ge, Huaijun Zhu, Guorong Han

Subjects: “…tenofovir alafenamide…”
Get full text

Should tenofovir ever be used in association with didanosine? by Ricardo Sobhie Diaz

Get full text

Fanconi syndrome induced by tenofovir in HIV patients by Mounira Rai, Amel Ouyahia, Abdelkader Gasmi, Wahiba Guenifi, Abdelmadjid Lacheheb

Get full text

Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid by Eric H. Decloedt, Phumla Z. Sinxadi, Lubbe Wiesner, John A. Joska, David W. Haas, Gary Maartens

Subjects: Get full text

Inflammatory properties of tenofovir in human liver cells by Songezo Vazi, Sanet van Zyl, Roné Vorster -de Wet, Charlette Tiloke

Subjects: Get full text

Media reporting of tenofovir trials in Cambodia and Cameroon by Wong Elaine, Wu Ping, Rachlis Beth, Mills Edward, Wilson Kumanan, Singh Sonal

“…<p>Abstract</p> <p>Background</p> <p>Two planned trials of pre-exposure prophylaxis tenofovir in Cambodia and Cameroon to prevent HIV infection in high-risk populations were closed due to activist pressure on host country governments. …”
Get full text

Correction: Mucosal effects for tenofovir 1% gel by Florian Hladik, Adam Burgener, Lamar Ballweber, Raphael Gottardo, Lucia Vojtech, Slim Fourati, James Y Dai, Mark J Cameron, Johanna Strobl, Sean M Hughes, Craig Hoesley, Philip Andrew, Sherri Johnson, Jeanna Piper, David R Friend, T Blake Ball, Ross D Cranston, Kenneth H Mayer, M Juliana McElrath, Ian McGowan

Get full text

Blaschkoid lichenoid drug eruption due to tenofovir by RekhaVirath, Manisha Balai, Lalit Kumar Gupta

Get full text

Tenofovir for children and adults with chronic hepatitis B by Li, Huijuan, Yang, Minyan, Ma, Mina, Li, Zijun, Li, Meixuan, Zhu, LongDong, Yao, Liang, Li, Junfeng, Zhong, Linda Lidan, Yang, Kehu

“…To evaluate the benefits and harms of tenofovir versus no intervention or placebo for children and adults with chronic hepatitis B.…”
Get full text

Hypophosphataemia with non-tenofovir-containing antiretroviral therapy. by Wainwright, E, Sherrard, J, Duncan, S, Shine, B, Dorrell, L

“…Hypophosphataemia with tenofovir (TDF) treatment has been well described. …”

Media reporting of tenofovir trials in Cambodia and Cameroon

“…Background Two planned trials of pre-exposure prophylaxis tenofovir in Cambodia and Cameroon to prevent HIV infection in high-risk populations were closed due to activist pressure on host country governments. …”